Anika Therapeutics, Inc. (ANIK) NASDAQ

15.14

+0.32(+2.16%)

Updated at May 20 04:00PM

Currency In USD

Key Executives

Name	Title	Pay	Year Born
Stephen D. Griffin	President, Principal Financial Officer, CEO & Director	818,148	1986
Ian W. McLeod	Senior VP, Chief Accounting Officer & Treasurer	489,601	1966
David Colleran	Executive Vice President, General Counsel & Corporate Secretary	724,581	1972
Cheryl Renee Blanchard	Executive Chair	1.41M	1964
James Chase	Senior Vice President of International Sales & Marketing	0	N/A
Mark Namaroff	Vice President of Investor Relations, ESG & Corporate Communications	0	1963
Matthew Hall	Director of Corporate Development & Investor Relations	0	N/A
Lisa Funiciello	VP & Chief Human Resources Officer	0	N/A
Mira Leiwant	Senior Vice President of Regulatory, Quality & Clinical Affairs	0	N/A
Ben Joseph	Vice President of Commercial & Corporate Development	0	N/A

Name

Title

Pay

Year Born

Stephen D. Griffin

President, Principal Financial Officer, CEO & Director

818,148

1986

Ian W. McLeod

Senior VP, Chief Accounting Officer & Treasurer

489,601

1966

David Colleran

Executive Vice President, General Counsel & Corporate Secretary

724,581

1972

Cheryl Renee Blanchard

Executive Chair

1.41M

1964

James Chase

Senior Vice President of International Sales & Marketing

N/A

Mark Namaroff

Vice President of Investor Relations, ESG & Corporate Communications

1963

Matthew Hall

Director of Corporate Development & Investor Relations

N/A

Lisa Funiciello

VP & Chief Human Resources Officer

N/A

Mira Leiwant

Senior Vice President of Regulatory, Quality & Clinical Affairs

N/A

Ben Joseph

Vice President of Commercial & Corporate Development

N/A

Description

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.